91 related articles for article (PubMed ID: 3022672)
21. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.
Qualman SJ; Haupt HM; Yang P; Hamilton SR
Gastroenterology; 1984 Oct; 87(4):848-56. PubMed ID: 6088351
[TBL] [Abstract][Full Text] [Related]
22. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation.
Meredith GE; Halliday GM; Totterdell S
Parkinsonism Relat Disord; 2004 Jun; 10(4):191-202. PubMed ID: 15120093
[TBL] [Abstract][Full Text] [Related]
23. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
[TBL] [Abstract][Full Text] [Related]
24. Lewy bodies in Betz cells of the motor cortex in a patient with Parkinson's disease.
Wakabayashi K; Mori F; Oyama Y; Kurihara A; Kamada M; Yoshimoto M; Takahashi H
Acta Neuropathol; 2003 Feb; 105(2):189-92. PubMed ID: 12536231
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
Lu L; Neff F; Alvarez-Fischer D; Henze C; Xie Y; Oertel WH; Schlegel J; Hartmann A
Exp Neurol; 2005 Sep; 195(1):27-39. PubMed ID: 15944136
[TBL] [Abstract][Full Text] [Related]
26. Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type.
Wisniewski T; Haltia M; Ghiso J; Frangione B
Am J Pathol; 1991 May; 138(5):1077-83. PubMed ID: 1850958
[TBL] [Abstract][Full Text] [Related]
27. [Lewy bodies, a misleading marker for Parkinson's disease?].
Duyckaerts C; Hauw JJ
Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
[TBL] [Abstract][Full Text] [Related]
28. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
[TBL] [Abstract][Full Text] [Related]
29. [An autopsy case of Parkinson's disease associated clinically with dementia terminating in akinetic mutism and pathologically with multiple Lewy's Bodies in the cerebral cortex].
Okeda R; Kayano T; Funata N; Kojima T; Miki M; Iwama H
No To Shinkei; 1982 Aug; 34(8):761-7. PubMed ID: 6289855
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease.
Hirsch E; Ruberg M; Dardenne M; Portier MM; Javoy-Agid F; Bach JF; Agid Y
Brain Res; 1985 Oct; 345(2):374-8. PubMed ID: 2994847
[TBL] [Abstract][Full Text] [Related]
32. Common epitopes of human and murine Mallory bodies and Lewy bodies as revealed by a neurofilament antibody.
Preisegger KH; Zatloukal K; Spurej G; Riegelnegg D; Denk H
Lab Invest; 1992 Feb; 66(2):193-9. PubMed ID: 1370966
[TBL] [Abstract][Full Text] [Related]
33. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
34. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
35. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
[TBL] [Abstract][Full Text] [Related]
36. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
[TBL] [Abstract][Full Text] [Related]
37. The frequency of Lewy bodies in a consecutive autopsy series.
Lindboe CF; Hansen HB
Clin Neuropathol; 1998; 17(4):204-9. PubMed ID: 9707335
[TBL] [Abstract][Full Text] [Related]
38. Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains.
Nishimura M; Tomimoto H; Suenaga T; Nakamura S; Namba Y; Ikeda K; Akiguchi I; Kimura J
Brain Res; 1994 Jan; 634(2):339-44. PubMed ID: 8131084
[TBL] [Abstract][Full Text] [Related]
39. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
40. Altered neurofilament expression does not contribute to Lewy body formation.
Bergeron C; Petrunka C; Weyer L; Pollanen MS
Am J Pathol; 1996 Jan; 148(1):267-72. PubMed ID: 8546215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
